Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a smartphone app ease end-of-life care? new study explores digital support for patients and families.

NCT ID NCT07491679

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a web-based platform and app can help patients receiving palliative care at home, along with their families and caregivers, track symptoms and well-being. About 150 adults in North Rhine-Westphalia are using the tool while researchers measure its ease of use and impact on quality of life. The goal is to find practical ways to improve digital support in end-of-life care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population includes adult patients receiving Specialized Outpatient Palliative Care (SAPV) or Palliative Care Consultation (PKD) from participating tertiary hospitals in Münster, Essen and nearby locations, Germany. Participants comprise newly admitted patients as well as patients already in care when inclusion is deemed appropriate by the care team. The population also includes relatives who support or accompany the patient care, as well as professional healthcare providers involved in the patient's palliative care. All participants must be able to provide written informed consent or have consent proved by a legally authorized representative.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (\>18 years) receiving care from participating SAPV/PKD (Specialized Outpatient Palliative Care / Palliative Care Consultation teams) * Newly admitted patients or those already in care if study participation is deemed appropriate by the care team * Patients with a direct treatment context to the Central Palliative Care Unit (ZEP) of the University Hospital Muenster * Ability to provide written informed consent Exclusion Criteria: * Minors (\<18 years) * Individuals with language or communication barriers that cannot be reliably compensated by relatives or qualified interpreters * Impaired consciousness or reduced decision-making capacity

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End of life are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Death

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital Muenster

    Münster, 48149, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.